LATEST

• REGULATORY MHLW to Carefully Prepare Rollout of OTC-Like Drug Charge System
  June 22, 2026

• BUSINESS Daiichi Sankyo CEO’s Pay Rises to 273 Million Yen in FY2025
  June 22, 2026

• REGULATORY LDP, Ishin Still at Odds on Social Security Reform; Pharma Role in Chuikyo Gains Traction
  June 19, 2026

• REGULATORY MHLW Panel OKs Technical Review Group for OTC-Like Drug Charge System
  June 19, 2026

• BUSINESS Shionogi/F2G’s Novel Antifungal Makes Mark, New Option in Resistant Cases
  June 19, 2026

• REGULATORY MHLW Official Warns of High Risks from GLP-1 Use in Cosmetic Weight Loss
  June 19, 2026

• BUSINESS Axcelead Joins Lilly’s TuneLab AI Drug Discovery Platform
  June 19, 2026

• BUSINESS Create BioVentures Sets Sail as Drug Discovery Bridge Builder
  June 19, 2026

• BUSINESS Merck Japan Expands Fertility Benefits, Raises Lifetime Cap to 18 Million Yen
  June 19, 2026

• REGULATORY LDP to Launch Study Group on Lag and Loss of Pediatric Cancer Drugs
  June 19, 2026

• REGULATORY LDP Patch League Urges Drug Price Support as Costs Continue to Climb
  June 19, 2026

• BUSINESS Santen CEO Paid 251 Million Yen in FY2025, COO Joins Disclosure List
  June 19, 2026

• ORGANIZATION Japanese Drug Makers Step Up Use of ASEAN Reliance Reviews
  June 18, 2026

• BUSINESS Teijin to Divest Feburic, Bonalon, Other Legacy Brands to LTL
  June 18, 2026

• BUSINESS Acumen Exercises Option for Up to Two JCR-Enabled AD Candidates
  June 18, 2026

• BUSINESS Takeda CEO Pulls in 2.3 Billion Yen in FY2025
  June 18, 2026

• BUSINESS Elevidys Needs More Safety Data to Support Full Approval: Expert
  June 18, 2026

• BUSINESS Sawai’s Revlimid Generic Gains Additional Lymphoma Indications
  June 18, 2026

• REGULATORY Nippon Ishin Calls for Pharma to Be Designated Strategic Industry
  June 18, 2026

• BUSINESS Efient AGs Widen Labels to Close Indication Gap
  June 18, 2026

ページ

• « 先頭
• ‹ Prev
• …
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• …
• Next ›
• 最終 »